+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Animal Antibiotics & Antimicrobials Market Research Report by Product (Aminoglycosides, Cephalosporins, and Fluoroquinolones), Mode of Delivery, Type of Animal, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 159 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5122286
UP TO OFF until Dec 31st 2022
The United States Animal Antibiotics & Antimicrobials Market size was estimated at USD 959.62 million in 2021, USD 1,054.97 million in 2022, and is projected to grow at a CAGR 6.51% to reach USD 1,401.07 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Animal Antibiotics & Antimicrobials to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Aminoglycosides, Cephalosporins, Fluoroquinolones, Lincosamides, Macrolides, Penicillins, Sulfonamides, and Tetracyclines.
  • Based on Mode of Delivery, the market was studied across Injections, Oral Powders, Oral Solutions, and Premixes.
  • Based on Type of Animal, the market was studied across Companion Animals and Food-Producing Animals. The Companion Animals is further studied across Cats, Dogs, and Horses. The Food-Producing Animals is further studied across Cattle, Pigs, Poultry, and Sheep and Goats.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Animal Antibiotics & Antimicrobials market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Antibiotics & Antimicrobials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Animal Antibiotics & Antimicrobials Market, including Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Eli Lilly and Company, Merck & Co., Inc., Sanofi, Vetoquinol S.A., Virbac, and Zoetis, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Animal Antibiotics & Antimicrobials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Animal Antibiotics & Antimicrobials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Animal Antibiotics & Antimicrobials Market?
4. What is the competitive strategic window for opportunities in the United States Animal Antibiotics & Antimicrobials Market?
5. What are the technology trends and regulatory frameworks in the United States Animal Antibiotics & Antimicrobials Market?
6. What is the market share of the leading vendors in the United States Animal Antibiotics & Antimicrobials Market?
7. What modes and strategic moves are considered suitable for entering the United States Animal Antibiotics & Antimicrobials Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Animal Antibiotics & Antimicrobials Market, by Product
6.1. Introduction
6.2. Aminoglycosides
6.3. Cephalosporins
6.4. Fluoroquinolones
6.5. Lincosamides
6.6. Macrolides
6.7. Penicillins
6.8. Sulfonamides
6.9. Tetracyclines
7. Animal Antibiotics & Antimicrobials Market, by Mode of Delivery
7.1. Introduction
7.2. Injections
7.3. Oral Powders
7.4. Oral Solutions
7.5. Premixes
8. Animal Antibiotics & Antimicrobials Market, by Type of Animal
8.1. Introduction
8.2. Companion Animals
8.2.1. Cats
8.2.2. Dogs
8.2.3. Horses
8.3. Food-Producing Animals
8.3.1. Cattle
8.3.2. Pigs
8.3.3. Poultry
8.3.4. Sheep and Goats
9. California Animal Antibiotics & Antimicrobials Market10. Florida Animal Antibiotics & Antimicrobials Market11. Illinois Animal Antibiotics & Antimicrobials Market12. New York Animal Antibiotics & Antimicrobials Market13. Ohio Animal Antibiotics & Antimicrobials Market14. Pennsylvania Animal Antibiotics & Antimicrobials Market15. Texas Animal Antibiotics & Antimicrobials Market
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Bayer AG
17.2. Boehringer Ingelheim GmbH
17.3. Ceva Sante Animale
17.4. Dechra Pharmaceuticals PLC
17.5. Eli Lilly and Company
17.6. Merck & Co., Inc.
17.7. Sanofi
17.8. Vetoquinol S.A.
17.9. Virbac
17.10. Zoetis, Inc.
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET DYNAMICS
FIGURE 8. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CEPHALOSPORINS, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CEPHALOSPORINS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY LINCOSAMIDES, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY LINCOSAMIDES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PENICILLINS, 2019-2027 (USD MILLION)
FIGURE 22. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PENICILLINS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2019-2027 (USD MILLION)
FIGURE 24. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2019-2027 (USD MILLION)
FIGURE 26. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2021 VS 2027 (%)
FIGURE 28. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2021 VS 2027 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2027
FIGURE 30. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY INJECTIONS, 2019-2027 (USD MILLION)
FIGURE 31. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY INJECTIONS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 32. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL POWDERS, 2019-2027 (USD MILLION)
FIGURE 33. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL POWDERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL SOLUTIONS, 2019-2027 (USD MILLION)
FIGURE 35. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL SOLUTIONS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PREMIXES, 2019-2027 (USD MILLION)
FIGURE 37. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PREMIXES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2021 VS 2027 (%)
FIGURE 39. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2021 VS 2027 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2027
FIGURE 41. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2019-2027 (USD MILLION)
FIGURE 42. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 43. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATS, 2019-2027 (USD MILLION)
FIGURE 44. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 45. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DOGS, 2019-2027 (USD MILLION)
FIGURE 46. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DOGS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 47. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY HORSES, 2019-2027 (USD MILLION)
FIGURE 48. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY HORSES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 49. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2019-2027 (USD MILLION)
FIGURE 50. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 51. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATTLE, 2019-2027 (USD MILLION)
FIGURE 52. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATTLE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 53. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PIGS, 2019-2027 (USD MILLION)
FIGURE 54. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PIGS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 55. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POULTRY, 2019-2027 (USD MILLION)
FIGURE 56. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POULTRY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 57. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SHEEP AND GOATS, 2019-2027 (USD MILLION)
FIGURE 58. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SHEEP AND GOATS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 59. CALIFORNIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. FLORIDA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. ILLINOIS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. NEW YORK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. OHIO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. PENNSYLVANIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. TEXAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 67. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CEPHALOSPORINS, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY LINCOSAMIDES, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PENICILLINS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY INJECTIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL POWDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL SOLUTIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PREMIXES, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATS, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DOGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY HORSES, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATTLE, BY STATE, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PIGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POULTRY, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SHEEP AND GOATS, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. CALIFORNIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 30. CALIFORNIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 31. CALIFORNIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2019-2027 (USD MILLION)
TABLE 32. CALIFORNIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2019-2027 (USD MILLION)
TABLE 33. FLORIDA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 34. FLORIDA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 35. FLORIDA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2019-2027 (USD MILLION)
TABLE 36. FLORIDA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2019-2027 (USD MILLION)
TABLE 37. ILLINOIS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. ILLINOIS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 39. ILLINOIS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2019-2027 (USD MILLION)
TABLE 40. ILLINOIS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2019-2027 (USD MILLION)
TABLE 41. NEW YORK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. NEW YORK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 43. NEW YORK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2019-2027 (USD MILLION)
TABLE 44. NEW YORK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2019-2027 (USD MILLION)
TABLE 45. OHIO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. OHIO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 47. OHIO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2019-2027 (USD MILLION)
TABLE 48. OHIO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2019-2027 (USD MILLION)
TABLE 49. PENNSYLVANIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. PENNSYLVANIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 51. PENNSYLVANIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2019-2027 (USD MILLION)
TABLE 52. PENNSYLVANIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2019-2027 (USD MILLION)
TABLE 53. TEXAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. TEXAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 55. TEXAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2019-2027 (USD MILLION)
TABLE 56. TEXAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2019-2027 (USD MILLION)
TABLE 57. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 58. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 59. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 60. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET RANKING
TABLE 61. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 62. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET MERGER & ACQUISITION
TABLE 63. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 64. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 65. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET INVESTMENT & FUNDING
TABLE 66. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 67. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: LICENSE & PRICING

Companies Mentioned

  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Sanofi
  • Vetoquinol S.A.
  • Virbac
  • Zoetis, Inc.

Methodology

Loading
LOADING...